Genscript Biotech Aligns Interests with Restricted Share Grant

Genscript Biotech (HK:1548) has released an update.

Genscript Biotech Corporation has announced the granting of 814,302 restricted shares to its directors and employees, with the aim of aligning their interests with the company’s performance. These shares, issued under the 2021 RSA Scheme, have no purchase price and are subject to a vesting period of approximately three years. The directors’ restricted shares do not have performance targets, while the employees’ shares are conditional on meeting specific performance criteria.

For further insights into HK:1548 stock, check out TipRanks’ Stock Analysis page.